Scarlet Fever (Streptococcus pyogenes - Group A Streptococcus)
Overview
Plain-Language Overview
Scarlet Fever is an infection caused by bacteria called Group A Streptococcus that mainly affects the throat and skin. It often starts with a sore throat and fever, followed by a distinctive red rash that feels like sandpaper. The rash usually appears on the chest and spreads to other parts of the body. Other common symptoms include a strawberry-like appearance of the tongue, flushed face, and peeling skin after the rash fades. This illness primarily involves the immune system reacting to bacterial toxins, which can cause discomfort and fever. If untreated, it can lead to complications affecting the heart or kidneys.
Clinical Definition
Scarlet Fever is an acute systemic illness caused by infection with toxigenic strains of Group A Streptococcus (GAS), specifically those producing erythrogenic exotoxins. It is characterized by a diffuse, finely papular, erythematous rash that typically begins on the neck and chest and spreads centrifugally. The rash is accompanied by pharyngitis, fever, and a strawberry tongue due to desquamation of the tongue epithelium. The pathogenesis involves a type IV hypersensitivity reaction to streptococcal pyrogenic exotoxins. The disease primarily affects children and is significant due to potential complications such as rheumatic fever and post-streptococcal glomerulonephritis. Diagnosis is clinical but supported by microbiological confirmation of GAS infection.
Inciting Event
Infection of the oropharynx by toxin-producing Streptococcus pyogenes strains initiates disease.
Exposure to respiratory droplets from an infected individual is the primary mode of transmission.
Antecedent streptococcal pharyngitis or tonsillitis precedes rash development.
Contact with contaminated fomites can also serve as a source of infection.
Latency Period
Symptoms typically develop 1 to 4 days after initial streptococcal infection.
The characteristic rash appears within 12 to 48 hours after onset of sore throat.
Fever and systemic symptoms precede rash by about 1 day.
Diagnostic Delay
Early symptoms mimic common viral pharyngitis leading to initial misdiagnosis.
Rash may be subtle or mistaken for other exanthems such as measles or rubella.
Lack of awareness of scarlet fever resurgence can delay clinical suspicion.
Failure to perform a rapid antigen detection test or throat culture delays confirmation.
Clinical Presentation
Signs & Symptoms
Fever and sore throat are initial presenting symptoms
Diffuse erythematous rash with sandpaper texture appearing 1-2 days after fever onset
Strawberry tongue and flushed face with circumoral pallor
Pharyngitis with tonsillar exudates and tender cervical lymphadenopathy
Desquamation of the skin, especially on the fingertips and toes, occurs during recovery
History of Present Illness
Initial presentation includes sore throat, fever, and malaise.
Within 1-2 days, a diffuse erythematous rash develops, starting on the neck and spreading to the trunk and extremities.
The rash has a characteristic sandpaper texture and is accompanied by circumoral pallor.
Patients often report a strawberry tongue with prominent papillae.
Desquamation of the skin occurs during the recovery phase, typically starting on the face and hands.
Past Medical History
History of recent streptococcal pharyngitis or skin infection increases risk.
Previous episodes of scarlet fever or rheumatic fever may be relevant.
Lack of prior antibiotic treatment for streptococcal infections can predispose to complications.
Immunodeficiency states may alter disease severity but are not typical risk factors.
Family History
No specific heritable syndromes are associated with scarlet fever.
Family members in close contact may have concurrent or recent streptococcal infections.
Clusters of scarlet fever cases in families reflect contagious transmission rather than genetic predisposition.
Physical Exam Findings
Diffuse erythematous rash with a sandpaper texture, typically starting on the trunk and spreading to extremities
Strawberry tongue characterized by prominent red papillae on a white-coated tongue
Pastia's lines, which are linear petechiae in skin folds such as the antecubital fossa
Circumoral pallor with flushed cheeks
Pharyngeal erythema and tonsillar exudates
Diagnostic Workup
Diagnostic Criteria
Diagnosis of scarlet fever is based on the presence of a characteristic sandpaper-like rash, pharyngitis, and fever in a patient with recent exposure to Group A Streptococcus. Key findings include a strawberry tongue and circumoral pallor. Confirmation is achieved by a positive throat culture or rapid antigen detection test for Group A Streptococcus. The rash typically spares the palms and soles, and desquamation occurs during recovery.
Pathophysiology
Key Mechanisms
Production of erythrogenic exotoxins (superantigens) by Streptococcus pyogenes triggers a systemic immune response causing the characteristic scarlatiniform rash.
M protein on the bacterial surface mediates adherence and immune evasion, facilitating infection.
Immune complex formation and cross-reactivity can lead to post-streptococcal complications such as rheumatic fever.
Toxin-mediated capillary damage results in the diffuse erythematous rash and strawberry tongue.
Activation of T cells by superantigens causes widespread cytokine release contributing to systemic symptoms.
| Involvement | Details |
|---|---|
| Organs | Throat (pharynx) is the initial site of Group A Streptococcus infection causing pharyngitis and serving as the portal of entry for scarlet fever. |
Skin manifests the characteristic rash due to systemic toxin effects. | |
Heart may be affected in post-infectious complications such as rheumatic fever, which can follow untreated scarlet fever. | |
| Tissues | Skin is the primary tissue affected, showing a diffuse erythematous rash with a sandpaper texture due to toxin-mediated inflammation. |
Pharyngeal mucosa is inflamed and erythematous, often with exudates, reflecting the site of initial infection. | |
Lymphoid tissue in the tonsils and cervical lymph nodes becomes enlarged and tender due to immune activation. | |
| Cells | Neutrophils are the primary immune cells that infiltrate tissues to phagocytose Streptococcus pyogenes during scarlet fever. |
T helper cells mediate the immune response by recognizing streptococcal superantigens and releasing cytokines. | |
B cells produce antibodies against streptococcal antigens, contributing to immune clearance and potential immune-mediated complications. | |
| Chemical Mediators | Streptococcal pyrogenic exotoxins act as superantigens triggering massive T cell activation and cytokine release, causing the characteristic rash and systemic symptoms. |
Interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α) are elevated during infection, mediating fever and inflammation. | |
C-reactive protein (CRP) levels increase as an acute phase reactant reflecting systemic inflammation. |
Treatments
Pharmacological Treatments
Penicillin
- Mechanism:
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to bacterial lysis.
- Side effects:
Allergic reactions
Gastrointestinal upset
Rare anaphylaxis
- Clinical role:
First-line
Amoxicillin
- Mechanism:
Bactericidal antibiotic that inhibits cell wall synthesis in Streptococcus pyogenes.
- Side effects:
Rash
Diarrhea
Allergic reactions
- Clinical role:
First-line
Erythromycin
- Mechanism:
Macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.
- Side effects:
Gastrointestinal upset
QT prolongation
Cholestatic hepatitis
- Clinical role:
Second-line
Non-pharmacological Treatments
Supportive care including hydration and antipyretics to manage fever and discomfort.
Isolation to prevent transmission of Group A Streptococcus via respiratory droplets.
Prevention
Pharmacological Prevention
Penicillin V or amoxicillin prophylaxis in close contacts to prevent spread
Intramuscular benzathine penicillin G for patients with recurrent infections or rheumatic fever history
No vaccine currently available for Streptococcus pyogenes
Non-pharmacological Prevention
Hand hygiene and respiratory etiquette to reduce transmission
Avoidance of close contact with infected individuals during contagious period
Prompt treatment of streptococcal pharyngitis to prevent progression to scarlet fever
Disinfection of shared surfaces in schools and daycare settings
Outcome & Complications
Complications
Acute rheumatic fever due to autoimmune cross-reactivity following untreated infection
Post-streptococcal glomerulonephritis presenting with hematuria and edema
Toxic shock syndrome caused by streptococcal exotoxins in severe cases
Peritonsillar abscess as a suppurative complication
Pneumonia secondary to bacterial spread
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Scarlet Fever (Streptococcus pyogenes - Group A Streptococcus) versus Kawasaki Disease
Scarlet Fever (Streptococcus pyogenes - Group A Streptococcus) | Kawasaki Disease |
|---|---|
Commonly affects children 5 to 15 years old | Primarily affects children under 5 years old |
Fever typically lasts 2 to 5 days with rapid onset of rash | Prolonged fever lasting more than 5 days with mucocutaneous inflammation |
Leukocytosis with neutrophilia and elevated antistreptolysin O titers | Elevated inflammatory markers with thrombocytosis in subacute phase |
Positive throat culture or rapid antigen test for Streptococcus pyogenes | No specific serologic test; diagnosis based on clinical criteria |
Scarlet Fever (Streptococcus pyogenes - Group A Streptococcus) versus Viral Pharyngitis (e.g., Adenovirus)
Scarlet Fever (Streptococcus pyogenes - Group A Streptococcus) | Viral Pharyngitis (e.g., Adenovirus) |
|---|---|
Caused by Streptococcus pyogenes, a bacterial pathogen | Caused by viruses such as adenovirus or Epstein-Barr virus |
Neutrophilic leukocytosis and positive bacterial cultures or rapid antigen test | Lymphocytic predominance on CBC and negative bacterial cultures |
Absence of cough and conjunctivitis; presence of strawberry tongue and sandpaper rash | Symptoms often include cough, conjunctivitis, and hoarseness |
Responds well to penicillin or amoxicillin therapy | Does not respond to antibiotics; supportive care only |
Scarlet Fever (Streptococcus pyogenes - Group A Streptococcus) versus Toxic Shock Syndrome (Staphylococcus aureus)
Scarlet Fever (Streptococcus pyogenes - Group A Streptococcus) | Toxic Shock Syndrome (Staphylococcus aureus) |
|---|---|
Caused by Streptococcus pyogenes producing erythrogenic exotoxins | Caused by Staphylococcus aureus producing superantigens |
Fever with characteristic rash and desquamation but less systemic shock initially | Rapid onset of high fever, hypotension, and multiorgan involvement |
Blood cultures usually negative; diagnosis based on throat culture | Blood cultures often positive for S. aureus |
Responds to beta-lactam antibiotics targeting S. pyogenes | Requires aggressive supportive care and anti-staphylococcal antibiotics |
Scarlet Fever (Streptococcus pyogenes - Group A Streptococcus) versus Measles (Rubeola)
Scarlet Fever (Streptococcus pyogenes - Group A Streptococcus) | Measles (Rubeola) |
|---|---|
Exposure to individuals with streptococcal pharyngitis or scarlet fever | Exposure to unvaccinated individuals or outbreaks in unimmunized populations |
Sudden onset of sore throat, fever, and sandpaper rash without conjunctivitis | Prodrome of cough, coryza, conjunctivitis followed by Koplik spots and maculopapular rash |
Positive rapid antigen test or culture for Streptococcus pyogenes | Serologic detection of measles IgM antibodies or PCR |
Scarlet Fever (Streptococcus pyogenes - Group A Streptococcus) versus Scarletina-like Drug Eruption
Scarlet Fever (Streptococcus pyogenes - Group A Streptococcus) | Scarletina-like Drug Eruption |
|---|---|
Recent streptococcal infection or contact with infected individuals | Recent exposure to drugs such as ampicillin or sulfonamides |
Rash develops concurrently with streptococcal pharyngitis symptoms | Rash develops after drug exposure and may recur with re-exposure |
Positive throat culture and elevated antistreptolysin O titers | Negative streptococcal cultures and absence of elevated antistreptolysin O titers |